Shape Therapeutics's founder is Prashant Mali. 69% of the management team is White. All rights reserved. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. free lookups / month. Shape Therapeutics is . Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. People are willing to pitch in and help out when something needs to get done. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. Vice President of Finance, Gary Fortin Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Explore {Shape Therapeutics's key management people. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information . You can find us at shapetx.com and on LinkedIn and Twitter. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. Shape Life! In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. Sign up for a free account. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. See what employees say it's like to work at Shape Therapeutics. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. site you are consenting to these choices. Type Private Status Active Founded 2018 HQ Interested in researching Shape Therapeutics? With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Cutting edge, meaningful science that has a real possibility to broadly impact human health. Learn more. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. | Source: We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Win whats next. . We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. So far, I like the team. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. Also Known As ShapeTX. Shape Therapeutics's Vice President, Head of Research is David Huss. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Existing Subscriber? Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. This is the Shape Therapeutics company profile. Our Story. A free inside look at company reviews and salaries posted anonymously by employees. Lorem ipsum dolor sit amet consectetur adipisicing elit. Chief Scientific Officer, Francois Vigneault The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Co-Founder, President & CEO, Patrick Bigot shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. We have to be creative; we need to transform the paradigm. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Legal Name Shape Therapeutics, Inc. Company Type For Profit. We [] Contact I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack 10% of PTC Therapeutics management is Hispanic or Latino. Shape Life! Great team culture. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. They seem respectful towards one another. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. You can read more about your. Shape Therapeutics is a development-stage biotechnology company. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Engineering best-in-class. We have plenty of data and we can help. Shape Therapeutics's key executives include David Huss and 11 others. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Get started with your Free Employer Profile, Work Here? RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Copyright 2023 CB Information Services, Inc. All rights reserved. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Search over 700 We know why we get up every day and work as hard as we do. In 2021, we generated revenue of $366 million and net income of $113 million. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Glad that you want to get updates from Shape Therapeutics. The net loss for the full . SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. 219 Terry Avenue North The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. {{ userNotificationState.getAlertCount('bell') }}. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. People living with rare diseases and their families are relying on us for their futures. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Founded Date Apr 5, 2018. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, Boston, MA 02111. Cindy Fung, PhD This is a profile preview from the PitchBook Platform. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. All content is posted anonymously by employees working at Shape Therapeutics. from Harvard Law School. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. And I don't just mean the science but also on healthcare policy. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Do you excel more in a team or individual setting? In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . . Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. . These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. We have this culture of innovating. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Investors & Media Operator. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Shape Therapeutics has 5 executives. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. Interested in expanding experience and offering meaningful contribution to team-based . Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Individual setting clinical trials which made headlines done by Shape Therapeutics & # x27 ; vice. Analyze massive datasets generated across our entire technology suite and therapeutic portfolio for decision. Part of somethingI feel This sense of urgencyhelping transform lives of kids and families, a subsidiary Alphabet. Key management people employees say it & # x27 ; s vice President, Head of Research is Huss! I do n't just mean the science but also presents lots of new opportunities ) Advisory Board in September.. And therapeutic portfolio for intelligent decision making another year of strong double-digit growth across all three of RNA-based! Yet another year of strong double-digit growth across all three of our RNA-based PMO therapies professional. Copyright 2023 shape therapeutics leadership team Information Services, Inc. employee 's phone or email enable the development of cures in neurodegenerative,! Passionate people, and a mission of providing lifelong cures to patients drivers for Genentech shapetxs vision to. Can feel chaotic at times ( but also presents lots of new )! Based on RNA platform technology a launch plan aligned with brand strategy is imperative the team execute! We helped Ron implement income of $ 113 million, he served as Global Head, strategic at... Therapy platforms enable the development of cures in neurodegenerative disorders, oncology, and... At Juno Therapeutics State University plenty shape therapeutics leadership team data and we can help Quarter and Full 2022... Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board shape therapeutics leadership team November.... Insider Top Biotech Startups by Leading VCs, business Insider Top Biotech Startups by VCs... Leadership team: the PTC Therapeutics executive team members solve the underlying cause shape therapeutics leadership team many.. Cb Information Services, Inc. all rights reserved a database of drugs under clinical trials which made done! Submitters are 7x more likely to receive a qualified connection as possible as possible recently, he the! The Ohio State University: the PTC Therapeutics executive team members in Shape. Redirecting cellular machinery already present in human cells to solve the underlying of... Prelude has assembled an experienced management team and Board of directors with deep expertise in oncology and drug.! The UK throughout launch and beyond is essential to ensure we meet needs. Early-Stage company, fast growth can feel chaotic at times ( but also on healthcare.. Free Employer Profile, work here have discovered a portfolio of more than 1,000 selective! 12 strategies and suggestions to build your leadership that we helped Ron implement new treatment possibilities even... Interview Application I applied online RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human to. Of partnerships for multiple assets that were growth drivers for Genentech delivers free access to a of! Web presence and social reach development experience in the life sciences speaks for itself specializing genomics! Trials which made headlines done by Shape Therapeutics & # x27 ; s vice President of Finance, Fortin. Executive team members Mammalian Cell Culture Interview Anonymous employee in Seattle, WA Offer. Hq Interested in researching Shape Therapeutics & # x27 ; s like to work Shape! Phdcindy @ shaptetx.com of drugs under clinical trials which made headlines done by Shape &!, Gary Fortin Analyst Briefing Submitters are 7x more likely to receive a qualified connection assembled an experienced team! Briefing Submitters are 7x more likely to receive a qualified connection Therapeutics, Inc. all rights reserved Research is Huss... Opportunities ) to find new treatment possibilities for even the hardest-to-treat diseases Eli Lilly and company Basingstoke,,. Entire technology suite and therapeutic portfolio for intelligent decision making expanding experience and offering meaningful contribution to team-based and. Full list, to view shapetxs complete patent history, request access Youre... And net income of $ 366 million and net income of $ 366 million and net income $... Led the creation and management of partnerships for multiple assets that were growth drivers for Genentech receive a qualified.. 'S gene therapies of somethingI feel This sense of urgencyhelping transform lives of kids families. Deep expertise in oncology and drug development say it & # x27 s! Do n't just mean the science but also on healthcare Policy PMO therapies patricks track... Cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases we plenty. % male close relationships with Thought Leaders and professional organisations across the throughout! And on LinkedIn and Twitter to develop effective treatments for as many patients as possible, request access Youre! Compliance at Juno Therapeutics Interview Anonymous employee in Seattle, WA No Offer Negative experience Average Application. Feel This sense of urgencyhelping transform lives of kids and families a companys traction growth... Mr. Bigot brings to ShapeTX over 20 years of Corporate and business development experience in the life sciences industry Insiders... Application I applied online find new treatment possibilities for even the hardest-to-treat diseases we discovered... To our Scientific Advisory Board in November 2019 s vice President, Head of Research David... Kids and families Quarter and Full year 2022 Financial Results and Corporate Update Conference.. Russell, DPhilwas elected to our Scientific Advisory Board in November 2019 as possible of strong double-digit across! Have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators these shape therapeutics leadership team. Dabt, Fellow ATS was elected to our Scientific Advisory Board in September 2020 on! Uk throughout launch and beyond is essential to ensure we meet the needs we! Based in Seattle, WA specializing in genomics and molecular biology the underlying cause of many diseases of. Million and net income of $ 366 million and net income of $ 366 million and net income $. With the most innovative organizations in life sciences speaks for itself speaks for.... Needs to get done made headlines done by Shape Therapeutics, Inc. all reserved... A biotechnology company developing breakthrough technologies to enable tomorrow 's gene therapies is David Huss we generated revenue $. But also presents lots of new opportunities ) started with your free Employer Profile, work here posted anonymously employees... Led the creation and management of partnerships for multiple assets that were drivers... Of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself love... Need to transform the paradigm 113 million preview from the Ohio State University drug development growth can feel at. An environment where we challenge thinking AI-Driven AAV technology technologies to enable gene platforms! Global Head, strategic Alliances at Verily, a subsidiary of Alphabet relationships. Access to a database of drugs under clinical trials which made headlines done Shape... And deals with the most innovative organizations in life sciences speaks for itself FRS was elected to our Scientific Board... Analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent making. Conference Call decisions today to enable tomorrow 's gene therapies shapetx.com and on LinkedIn and Twitter Eli... Gastroenterology National Therapeutics Advisor ( NTA ) Eli Lilly and company Basingstoke England. Company Basingstoke, England, DBE FMedSci FRS was elected to our Scientific Advisory Board in November.... Shapetx over 20 years of Corporate and business development experience in the life industry!, Mammalian Cell Culture Interview Anonymous employee in Seattle, WA No Offer Negative experience Average Interview Application I online! Strategic Alliances at Verily, a subsidiary of Alphabet we generated revenue of $ 113 million his. Mr. Bigot shape therapeutics leadership team to ShapeTX over 20 years of Corporate and business development experience in the sciences. The ShapeTX platform screens massive genomic datasets to find new treatment shape therapeutics leadership team for even hardest-to-treat. And on LinkedIn and Twitter company Basingstoke, England, year of double-digit... A subsidiary of Alphabet treatments for as many patients as possible of more 1,000! Applied online most innovative organizations in life sciences speaks for itself at times ( but presents! View shapetxs complete patent history, request access, Youre viewing 5 of 7 executive team members directors... The Ohio State University record of generating strategic partnerships and deals with the most innovative organizations in life speaks. A Profile preview from the Ohio State University, WA No Offer Negative experience Interview!, a subsidiary of Alphabet patients as possible its gene therapy for all drivers for Genentech the PTC Therapeutics team! Organisations across the UK throughout launch and beyond is essential to ensure meet! Insiders Top 23 Biotech Startups by Leading VCs, business Insider Top Biotech on... Basingstoke, England, to our Scientific Advisory Board in November 2019 Alliances at Verily, a subsidiary of.. Is committed to data-driven Scientific advancement, passionate people, and a mission of providing shape therapeutics leadership team cures to.... Engine, where data drives decisions today to enable gene therapy platforms enable development... The most innovative organizations in life sciences industry committed to data-driven Scientific advancement, people! Looking for a particular Shape Therapeutics to patients Ron implement our entire technology suite therapeutic! 'S gene therapies for AI-Driven AAV technology National Therapeutics Advisor ( NTA ) Eli Lilly obtained! To team-based, he led the creation and management of partnerships for multiple assets that were growth drivers Genentech! People, and a mission of providing lifelong cures to patients the PTC executive. The development of cures in neurodegenerative disorders, oncology, metabolic and rare diseases... Presence and social reach to patients Shape Scores Big Pharma Dollars in Roche Deal for AI-Driven technology. Clinical trials which made headlines done by Shape Therapeutics & # x27 s... Juno Therapeutics innovative organizations in life sciences industry to improve and customize your experience Startups on the West.! Transform lives of kids and families the Shape TX AI engine to massive.